[
    [
        {
            "time": "2018-01-02",
            "original_text": "Pharma Must Use Tax-Reform Windfall To Make More Drugs Or Face Backlash - Part II",
            "features": {
                "keywords": [
                    "Pharma",
                    "Tax-Reform",
                    "Windfall",
                    "Drugs",
                    "Backlash"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 9,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        }
    ]
]